Maria de Lourdes Aguiar Oliveira is currently the Deputy Director of the Reference Laboratories, Ambulatories and Biological Collections, at the Oswaldo Cruz Institute. She graduated in Biological Sciences (1987), with a Masters (benchwork at the Robert Koch Institute, Germany, 1997) and PhD in Cellular and Molecular Biology at the Oswaldo Cruz Foundation (Fiocruz) (2008). Since 1987, she has been a technologist in Public Health at Fiocruz, and the Head of the Immunodiagnostic Sector, Department of Blood and Blood Derivatives, INCQS, Fiocruz (1992–1994). At the Oswaldo Cruz Institute, she developed research and epidemiological surveillance in viral hepatitis, influenza, and other respiratory viruses. She is experienced in the field of microbiology, with an emphasis on virology in the following topics: epidemiology, molecular epidemiology, viral evolution and phylogeny, epidemiological and environmental surveillance, SARS-CoV-2, influenza and other respiratory viruses, viral hepatitis, and injected drug use. She is a member of the Health Surveillance Working Group, Fiocruz, as well as other institutional committees, and coordinated the IOC Technical Chamber of Reference Laboratories (2017–2020).
Maria de Lourdes Aguiar Oliveira is currently the Deputy Director of the Reference Laboratories, Ambulatories and Biological Collections, at the Oswaldo Cruz Institute. She graduated in Biological Sciences (1987), with a Masters (benchwork at the Robert Koch Institute, Germany, 1997) and PhD in Cellular and Molecular Biology at the Oswaldo Cruz Foundation (Fiocruz) (2008). Since 1987, she has been a technologist in Public Health at Fiocruz, and the Head of the Immunodiagnostic Sector, Department of Blood and Blood Derivatives, INCQS, Fiocruz (1992–1994). At the Oswaldo Cruz Institute, she developed research and epidemiological surveillance in viral hepatitis, influenza, and other respiratory viruses. She is experienced in the field of microbiology, with an emphasis on virology in the following topics: epidemiology, molecular epidemiology, viral evolution and phylogeny, epidemiological and environmental surveillance, SARS-CoV-2, influenza and other respiratory viruses, viral hepatitis, and injected drug use. She is a member of the Health Surveillance Working Group, Fiocruz, as well as other institutional committees, and coordinated the IOC Technical Chamber of Reference Laboratories (2017–2020).